Rydex Russell 2000 Fund C (RYROX)
51.81
-1.17
(-2.21%)
USD |
Nov 19 2026
Key Stats
| Net Expense Ratio | Total Assets Under Management | Weighted Average Dividend Yield | Turnover Ratio (Generic) |
|---|---|---|---|
| 2.40% | 13.52M | 1.07% | 9.00% |
| 1 Year Fund Level Flows | 1 Year Total Returns (Daily) | Annualized Total Returns Since Inception (Daily) | Max Drawdown (Since Inception) |
| -989067.0 | 11.64% |
Basic Info
| Investment Strategy | |
| The Fund seeks to provide investment results that match the performance of a specific benchmark on a daily basis. The Fund's current benchmark is the Russell 2000 Index. The Fund will invest at least 80% of its assets in securities of companies in the underlying index. |
| General | |
| Security Type | Mutual Fund |
| Equity Style | Small Cap Core |
| Broad Asset Class | US Equity |
| Broad Category | Equity |
| Global Peer Group | Equity US Sm&Mid Cap |
| Peer Group | Small-Cap Core Funds |
| Global Macro | Equity North America |
| US Macro | Small-Cap Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Small-Cap Funds |
| Fund Owner Firm Name | Guggenheim |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
Fund Flows
Risk
Performance Versus Peer Group
Annual Total Returns Versus Peers
As of November 20, 2026.
Asset Allocation
As of September 30, 2026.
| Type | % Net |
|---|---|
| Cash | 25.72% |
| Stock | 72.10% |
| Bond | 7.61% |
| Convertible | 0.00% |
| Preferred | 0.00% |
| Other | -5.45% |
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
|
Reverse Repo General Security
|
25.23% | -- | -- |
| Vanguard Russell 2000 ETF | 11.83% | 106.70 | -2.21% |
| iShares Russell 2000 ETF | 11.82% | 264.22 | -2.18% |
| BNY Dreyfus Treasury Securities Cash Mgmt Inst | 6.29% | 1.00 | 0.00% |
| United States of America USGB 10/29/2026 FIX USD Government (Matured) | 0.67% | 100.00 | 0.01% |
|
USD Cash
|
0.37% | -- | -- |
| BNY Dreyfus Treasury Obligations Cash Mgmt Inst | 0.29% | 1.00 | 0.00% |
| Twist Bioscience Corp. | 0.21% | 111.62 | -4.07% |
| Moog, Inc. | 0.18% | 328.07 | -2.12% |
| 10X Genomics, Inc. | 0.17% | 57.38 | 0.54% |
Fees & Availability
| Fees | |
| Actual 12B-1 Fee | 1.00% |
| Actual Management Fee | 0.70% |
| Administration Fee | 554.00 None |
| Maximum Front Load | -- |
| Maximum Deferred Load | 1.00% |
| Maximum Redemption Fee | -- |
| General Availability | |
| Available for Insurance Product | No |
| Available for RRSP | No |
| Purchase Details | |
| Open to New Investors |
|
| Minimum Initial Investment | 2500.00 None |
| Minimum Subsequent Investment | 0.00 None |
TTM Distributions
| Type | Nov | Dec | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Qualified Income
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
Normal
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
Qualified
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
LT Cap Gains
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
Ordinary Income
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
Non-Qual
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
ST Cap Gains
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
Interest
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
Tax-Exempt
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
ROC
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
Other
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
Total
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
As of October 31, 2026.
Basic Info
| Investment Strategy | |
| The Fund seeks to provide investment results that match the performance of a specific benchmark on a daily basis. The Fund's current benchmark is the Russell 2000 Index. The Fund will invest at least 80% of its assets in securities of companies in the underlying index. |
| General | |
| Security Type | Mutual Fund |
| Equity Style | Small Cap Core |
| Broad Asset Class | US Equity |
| Broad Category | Equity |
| Global Peer Group | Equity US Sm&Mid Cap |
| Peer Group | Small-Cap Core Funds |
| Global Macro | Equity North America |
| US Macro | Small-Cap Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Small-Cap Funds |
| Fund Owner Firm Name | Guggenheim |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
Fundamentals
| General | |
| Distribution Yield | -- |
| Dividend Yield TTM (11-19-26) | 0.74% |
| 30-Day SEC Yield | -- |
| 7-Day SEC Yield | -- |
| Number of Holdings | 1991 |
| Stock | |
| Weighted Average PE Ratio | 26.40 |
| Weighted Average Price to Sales Ratio | 6.346 |
| Weighted Average Price to Book Ratio | 4.612 |
| Weighted Median ROE | -5.75% |
| Weighted Median ROA | -2.53% |
| Return on Investment (TTM) | -0.67% |
| Earning Yield | 0.0653 |
| LT Debt / Shareholders Equity | 1.478 |
| Number of Equity Holdings | 1979 |
| Bond | |
| Yield to Maturity (9-30-26) | -- |
| Effective Duration | -- |
| Average Coupon | -- |
| Calculated Average Quality | -- |
| Effective Maturity | -- |
| Nominal Maturity | -- |
| Number of Bond Holdings | 1 |
As of September 30, 2026
Growth Metrics
| EPS Growth (1Y) | 17.87% |
| EPS Growth (3Y) | 6.88% |
| EPS Growth (5Y) | 14.27% |
| Sales Growth (1Y) | 15.47% |
| Sales Growth (3Y) | 11.27% |
| Sales Growth (5Y) | 15.26% |
| Sales per Share Growth (1Y) | 138.4% |
| Sales per Share Growth (3Y) | 10.57% |
| Operating Cash Flow - Growth Rate (3Y) | 27.20% |
As of September 30, 2026
Top Portfolio Holders
| Name | % Weight |
|---|---|
| Portfolio A | 5.00% |
| Portfolio B | 3.50% |
| Portfolio C | 2.25% |
Excel Add-In Codes
| Name: =YCI("M:RYROX", "name") |
| Broad Asset Class: =YCI("M:RYROX", "broad_asset_class") |
| Broad Category: =YCI("M:RYROX", "broad_category_group") |
| Prospectus Objective: =YCI("M:RYROX", "prospectus_objective") |
| To find the codes for any of our securities and financial metrics, see our Complete Excel Reference. |